Related Experiment Videos

[The effect of the alimentary factor on erythrocyte ATPase activity in ischemic heart disease patients]

Voprosy Pitaniia
|May 1, 1987
PubMed

Insights

Coronary heart disease (CHD) in men is linked to impaired ion-transport ATPase function and hyperlipoproteinemia (HLP). Diet therapy can help normalize lipid metabolism and ATPase activity in CHD patients.

Area of Science:

  • Biochemistry
  • Cardiology
  • Human Physiology

Background:

  • Functional disorders of ion-transport ATPases are observed in patients with coronary heart disease (CHD).
  • The severity of ATPase activity impairment correlates with hyperlipoproteinemia (HLP) in CHD patients.

Purpose of the Study:

  • To investigate the relationship between ion-transport ATPase activity, cation concentrations, and lipid metabolism in men with CHD.
  • To evaluate the effects of anti-atherosclerotic dietotherapy on these parameters.

Main Methods:

  • Assessed general ATPase, Mg-ATPase, and Na, K-ATPase activities.
  • Measured cation concentrations (Mg2+, Na+) in plasma and erythrocytes.
  • Analyzed lipid metabolism parameters and correlated them with ATPase activity and cation levels.
  • Monitored changes after a course of anti-atherosclerotic dietotherapy.

Main Results:

  • ATPase activity impairment (general, Mg-ATPase, Na, K-ATPase) correlated with HLP in CHD patients.
  • Observed varied cation concentration changes in plasma and erythrocytes, not always correlating with HLP or ATPase activity.
  • Found positive correlations between elevated serum Mg2+ and erythrocyte Na+ with hypercholesterolemia.
  • Noted inverse correlations between decreased Mg2+, suppressed Mg-ATPase activity, and hypo-alpha-cholesterolemia.

Conclusions:

  • Ion-transport ATPase dysfunction is a feature of CHD in men, linked to HLP.
  • Dietary interventions show potential for normalizing lipid metabolism and improving ion-transport ATPase function in CHD patients.

Related Concept Videos